Study: Medicare could save $3.6 billion at Mark Cuban’s prices
A recent study found that Medicare could have saved $3.6 billion in 2020 on the costs of generic drugs if it had bought them at the same prices paid by the Mark Cuban Cost Plus Drug Co.
The study, published June 20 in Annals of…